Table 4.
Treatment risks | Mild side effect | Serious infection | Serious side effect | ||||
Coefficient | SE | Coefficient | SE | Coefficient | SE | ||
Mean MAR (%) | 21.73 | 4.38 | 8.93 | 1.81 | −0.28 | 0.80 | |
Age | 18–60 | 2.66 | 1.94 | 2.06 | 0.78 | 0.44 | 0.36 |
60 or over | −2.66 | 1.94 | −2.06 | 0.78 | −0.44 | 0.36 | |
Education | Below graduate | −0.37 | 1.68 | −0.51 | 0.67 | 0.22 | 0.31 |
Graduate or above | 0.37 | 1.68 | 0.51 | 0.67 | −0.22 | 0.31 | |
Health literacy | Low | −1.72 | 3.81 | 0.81 | 1.60 | −0.51 | 0.70 |
High | 1.72 | 3.81 | −0.81 | 1.60 | 0.51 | 0.70 | |
Subjective numeracy | Low | −0.69 | 2.25 | 0.81 | 0.89 | −0.21 | 0.40 |
High | 0.69 | 2.25 | −0.81 | 0.89 | 0.21 | 0.40 | |
Brief Illness Perception Questionnaire subscales | Consequences − | −1.58 | 2.01 | 1.31 | 0.80 | −0.13 | 0.37 |
Consequences + | 1.58 | 2.01 | −1.31 | 0.80 | 0.13 | 0.37 | |
Timeline − | −4.44 | 2.20 | −0.19 | 0.87 | −0.01 | 0.40 | |
Timeline + | 4.44 | 2.20 | 0.19 | 0.87 | 0.01 | 0.40 | |
Personal control − | −1.35 | 1.66 | −0.41 | 0.65 | −0.34 | 0.30 | |
Personal control + | 1.35 | 1.66 | 0.41 | 0.65 | 0.34 | 0.30 | |
Treatment control − | 1.72 | 1.59 | 0.47 | 0.62 | 0.03 | 0.29 | |
Treatment control + | −1.72 | 1.59 | −0.47 | 0.62 | −0.03 | 0.29 | |
Identity − | 1.55 | 1.66 | −0.82 | 0.66 | −0.24 | 0.30 | |
Identity + | −1.55 | 1.66 | 0.82 | 0.66 | 0.24 | 0.30 | |
Concern − | 0.71 | 1.92 | −1.41 | 0.76 | −0.38 | 0.35 | |
Concern + | −0.71 | 1.92 | 1.41 | 0.76 | 0.38 | 0.35 | |
Coherence − | 0.34 | 1.56 | −0.15 | 0.61 | −0.35 | 0.28 | |
Coherence + | −0.34 | 1.56 | 0.15 | 0.61 | 0.35 | 0.28 | |
Emotion − | −0.59 | 1.71 | −0.09 | 0.68 | 0.20 | 0.31 | |
Emotion + | 0.59 | 1.71 | 0.09 | 0.68 | −0.20 | 0.31 | |
Beliefs about Medicines Questionnaire-General subscales | Harm − | −2.03 | 1.67 | 0.00 | 0.66 | −0.26 | 0.30 |
Harm + | 2.03 | 1.67 | 0.00 | 0.66 | 0.26 | 0.30 | |
Overuse − | 1.37 | 1.63 | 0.44 | 0.64 | 0.31 | 0.29 | |
Overuse + | −1.37 | 1.63 | −0.44 | 0.64 | −0.31 | 0.29 | |
Perceived risk of RA | Very unlikely/unlikely/neutral | 3.34 | 1.55 | 0.22 | 0.61 | 0.09 | 0.28 |
Likely/very likely | −3.34 | 1.55 | −0.22 | 0.61 | −0.09 | 0.28 |
Boldface values denote estimated coefficients that are significant at the 5% level.
−, below median; +, above median.
MAR, maximum acceptable risk; RA, rheumatoid arthritis.